The formation of isomers may be attributed to initial nucleophilic attack of the NH2 group of the reagent
at the carbonyl carbon atom (regioisomers a, a') or the β-carbon and β'-carbon atoms of the substrates
(regioisomers b, b') with subsequent azacyclization.
Ar
Ar1
H
N
N
H
N
NH2
4
N
N
N
N
+
+
Ar1
Ar
Ar1
H
8
DMF
N
N
H
N
N
β1
β
H
O
Ar
1, 3, 4
2a, 5a, 6a
2b, 5b, 6b
Ar1
Ar
H
4
N
N
+
N
N
+
H
8
N
N
H
N
N
Ar
H
Ar1
2b'
2a'
1, 2a,b,a',b' Ar = 2-thienyl, Ar1 = Ph; 3, 5a,b Ar = Ar1 = Ph; 4, 6a,b Ar = Ar1 = 2-thienyl
Thus, we are the first to obtain spectral evidence for the formation of the angular b form in addition to
the major linear a form and establish the capacity of asymmetric dienone derivatives of cyclohexane to undergo
azacyclization through alternative pathways in their reaction with 3-amino-1,2,4-triazole.
1
13
The H and C NMR, HSQC, and NOESY spectra were obtained on a Varian-400 spectrometer at 400
1
13
and 100 MHz for the H and C NMR spectra, respectively, in CDCl3 with TMS as the internal standard. The
reaction course and purity of the products were followed by thin-layer chromatography on Silufol
UV-254 plates using 2:2:1 hexane–ethyl acetate–chloroform as the eluent.
8-Thienylidene-4-phenyl-3a,4,5,6,7,8,9,9a-octahydro[1,2,4]triazolo[3,4-b]quinazoline (2a), 8-Benzyl-
idene-4-thienyl-3a,4,5,6,7,8,9,9a-octahydro[1,2,4]triazolo[3,4-b]quinazoline
(2a'),
4-Thienylidene-
8-phenyl-3a,4,5,6,7,8,9,9a-octahydro[1,2,4]triazolo[3,4-b]quinazoline (2b), and 4-Benzylidene-4-thienyl-
3a,4,5,6,7,8,9,9a-octahydro[1,2,4]triazolo[3,4-b]quinazoline (2b'). A solution of 3-amino-1,2,4-triazole
(0.15 g, 2 mmol), 2-thienylidene-6-benzylidenecyclohexanone (1) (0.55 g, 2 mmol) in DMF (0.5 ml) was
heated at reflux for 2 h, cooled, distilled water added, filtered, and dried for 1 h at 125°C to give 0.48 g (69%)
product as light-yellow crystals; mp 232-234°C (DMF). 1H NMR spectrum, δ, ppm: 9.44, 9.54, 9.95, 10.02 (1H,
s, NH); 5.81, 6.13 (1H, s, H-4); 5.66, 5.86 (1H, s, H-8); 2.08-2.33 (2H, m, H-5); 1.64-2.04 (2H, m, H-6);
2.36-3.03 (2H, m, H-7); 7.51 (1H, s, H-2); 6.90-8.52 (8H, m, H Ar). Found, %: C 69.34; H 5.63; N 15.97.
C20H18N4S. Calculated, %: C 69.36; H 5.20; N 16.18.
8-Benzylidene-4-phenyl-3a,4,5,6,7,8,9,9a-octahydro[1,2,4]triazolo[3,4-b]quinazoline
(5a)
and
4-Benzylidene-8-phenyl-3a,4,5,6,7,8,9,9a-octahydro[1,2,4]triazolo[3,4-b]quinazoline (5b) were synthesized
1
analogously in 82% yield; mp 228-230°C (DMF) [2]. H NMR spectrum, δ, ppm: 9.39, 9.00 (1H, s, NH); 5.79
(1H, s, H-4); 5.64 (1H, s, H-8); 1.91-2.08 (2H, m, H-5); 1.59-1.74 (2H, m, H-6); 2.08-2.78 (2H, m, H-7); 7.41
(1H, s, H-2); 6.98-7.57 (10H, m, H Ar). Found, %: C 77.43; H 5.60; N 16.77. C22H20N4. Calculated, %: C 77.65;
H 5.88; N 16.47.
8-Thienylidene-4-thienyl-3a,4,5,6,7,8,9,9a-octahydro[1,2,4]triazolo[3,4-b]quinazoline (6a) and
4-Thienylidene-8-thienyl-3a,4,5,6,7,8,9,9a-octahydro[1,2,4]triazolo[3,4-b]quinazoline (6b) were synthesized
1015